Compare ABCL & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | DFIN |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2017 |
| Metric | ABCL | DFIN |
|---|---|---|
| Price | $4.16 | $39.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $8.40 | ★ $61.50 |
| AVG Volume (30 Days) | ★ 8.1M | 252.0K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | $75,128,000.00 | ★ $963,000,000.00 |
| Revenue This Year | N/A | $4.98 |
| Revenue Next Year | $21.85 | $3.87 |
| P/E Ratio | ★ N/A | $30.37 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $1.94 | $37.07 |
| 52 Week High | $6.52 | $66.25 |
| Indicator | ABCL | DFIN |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 28.31 |
| Support Level | $3.96 | $37.07 |
| Resistance Level | $4.84 | $50.09 |
| Average True Range (ATR) | 0.40 | 2.18 |
| MACD | -0.08 | -0.96 |
| Stochastic Oscillator | 21.93 | 8.61 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.